Griffett, K., & Burris, T. P. (2016). Promiscuous activity of the LXR antagonist GSK2033 in a mouse model of fatty liver disease. Biochem Biophys Res Commun.
Chicago ZitierstilGriffett, Kristine, und Thomas P. Burris. "Promiscuous Activity of the LXR Antagonist GSK2033 in a Mouse Model of Fatty Liver Disease." Biochem Biophys Res Commun 2016.
MLA ZitierstilGriffett, Kristine, und Thomas P. Burris. "Promiscuous Activity of the LXR Antagonist GSK2033 in a Mouse Model of Fatty Liver Disease." Biochem Biophys Res Commun 2016.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.